Search

Search Results
Results 89371 - 89380 of 89524 for cancer
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Hysone
    Drug - 28 Nov 2021
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • Acnatac
    Drug - 18 Nov 2021
    Consumer Medicine Information (CMI) about Acnatac intended for persons living in Australia.
  • Hygroton 25
    Drug - 20 Sep 2021
    Consumer Medicine Information (CMI) about Hygroton 25 (Chlortalidone) intended for persons living in Australia.
  • Toradol Injection
    Drug - 2 Sep 2021
    Consumer Medicine Information (CMI) about Toradol Injection intended for persons living in Australia.
  • Rabeprazole Mylan
    Drug - 22 Jan 2021
    Consumer Medicine Information (CMI) about Rabeprazole Mylan (rabeprazole sodium) intended for persons living in Australia.
  • Duodopa
    Drug - 23 Apr 2020
    Consumer Medicine Information (CMI) about Duodopa intended for persons living in Australia.
  • Using Analytical Techniques to Follow Standards for Seafood Safety
    White Paper - 15 Mar 2019
    Analytical Techniques GC-MS/MS has been used to identify PCBs and PAHs in seafood.
  • Test document
    Drug - 17 Jan 2019
    Consumer Medicine Information (CMI) about Test document (darbepoetin alfa) intended for persons living in Australia.
  • Update on Sudan I contamination
    News - 22 Feb 2005
    The Food Standards Agency has released an update on food products contaminated with the illegal dye Sudan I.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback